Netherlands' Corbion Q3 revenue rises year-on-year, maintains 2026 outlook
Overview
Netherlands sustainable ingredients firm's Q3 revenue rose 9.3% yr/yr, organic sales up 7.6%
Q3 adjusted EBITDA grew 29% yr/yr, margin improved to 18.8%
Company discontinued PLA divestment process after offers did not reflect business value
Outlook
Corbion maintains full-year 2026 guidance
Company says visibility into Q4 orderbook supports maintained 2026 outlook
Company sees ongoing cost-reduction initiatives and operational efficiencies supporting margins
Result Drivers
VOLUME/MIX GROWTH - Co said organic sales growth was driven by positive volume/mix development, especially in Health & Nutrition
OMEGA-3 DHA PRICES - Higher fish oil prices led to increased omega-3 DHA prices, positively impacting Health & Nutrition volume/mix
COST REDUCTION & EFFICIENCY - Adjusted EBITDA margin improvement attributed to cost-reduction initiatives and operational efficiencies
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
9M Revenue | EUR 971.60 mln | ||
9M Adjusted EBITDA Margin | 15.70% | ||
9M Operating Result | EUR 81.40 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for Corbion NV is €25.50, about 6.2% below its October 27 closing price of €27.20
The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 14 three months ago
Reuters Recommended Reads
Oct 27 - French glass packaging firm Verallia's Q3 revenue falls on lower volumes
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)